A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis

Psoriasis (OMIM 177900) is a chronic inflammatory skin disorder of unknown pathogenesis affecting ∼2% of the Western population. It occurs more frequently in individuals with human immunodeficiency virus, and 20–30% of individuals with psoriasis have psoriatic arthritis. Psoriasis is associated with HLA class I alleles, and previous linkage analysis by our group identified a second psoriasis locus at 17q24–q25 (PSORS2; ref. 7). Linkage to this locus was confirmed with independent family sets. Additional loci have also been proposed to be associated with psoriasis. Here we describe two peaks of strong association with psoriasis on chromosome 17q25 separated by 6 Mb. Associated single-nucleotide polymorphisms (SNPs) in the proximal peak lie in or near SLC9A3R1 (also called EBP50 and NHERF1) and NAT9, a new member of the N-acetyltransferase family. SLC9A3R1 is a PDZ domain–containing phosphoprotein that associates with members of the ezrin-radixin-moesin family and is implicated in diverse aspects of epithelial membrane biology and immune synapse formation in T cells. The distal peak of association is in RAPTOR (p150 target of rapamycin (TOR)-scaffold protein containing WD-repeats). Expression of SLC9A3R1 is highest in the uppermost stratum Malpighi of psoriatic and normal skin and in inactive versus active T cells. A disease-associated SNP lying between SLC9A3R1 and NAT9 leads to loss of RUNX1 binding. This is the second example of loss of a RUNX1 binding site associated with susceptibility to an autoimmune disease. It also suggests defective regulation of SLC9A3R1 or NAT9 by RUNX1 as a susceptibility factor for psoriasis.

[1]  A. Bowcock,et al.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. , 1994, Science.

[2]  J. Karvonen,et al.  Psoriasis and HLA‐Cw6 , 1980, The British journal of dermatology.

[3]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[4]  M. Miyazaki,et al.  Cutting Edge: Negative Regulation of Immune Synapse Formation by Anchoring Lipid Raft to Cytoskeleton Through Cbp-EBP50-ERM Assembly1 , 2002, The Journal of Immunology.

[5]  J. Ott,et al.  A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. , 2001, American journal of human genetics.

[6]  T. Paavonen,et al.  Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites. , 2002, The American journal of pathology.

[7]  A. Bretscher,et al.  Identification of EBP50: A PDZ-containing Phosphoprotein that Associates with Members of the Ezrin-Radixin-Moesin Family , 1997, The Journal of cell biology.

[8]  James T. Elder,et al.  Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. , 1997, Human molecular genetics.

[9]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[10]  Kristin A. Hogquist,et al.  Sweet 'n' sour: the impact of differential glycosylation on T cell responses , 2002, Nature Immunology.

[11]  R. Trembath,et al.  Searching for the major histocompatibility complex psoriasis susceptibility gene. , 2002, The Journal of investigative dermatology.

[12]  L. Samuelsson,et al.  Analysis of Three Suggested Psoriasis Susceptibility Loci in a Large Swedish Set of Families: Confirmation of Linkage to Chromosome 6p (HLA Region), and to 17q, but not to 4q , 1999, Human Heredity.

[13]  E. Wijsman.  A deductive method of haplotype analysis in pedigrees. , 1987, American journal of human genetics.

[14]  V. Kouskoff,et al.  Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. , 2002, Blood.

[15]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[16]  H. Drabkin,et al.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.

[17]  G. Abecasis,et al.  Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci , 2001, Nature Genetics.

[18]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[19]  P. Kwok,et al.  Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility , 2002, Human Genetics.

[20]  F. Clerget-Darpoux,et al.  Statistical properties of the allelic and genotypic transmission/disequilibrium test for multiallelic markers , 1995, Genetic epidemiology.

[21]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[22]  E. Martin,et al.  A test for linkage and association in general pedigrees: the pedigree disequilibrium test. , 2000, American journal of human genetics.

[23]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[24]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[25]  A. Bowcock,et al.  Genetics of psoriasis: the potential impact on new therapies. , 2003, Journal of the American Academy of Dermatology.

[26]  S. Shenolikar,et al.  Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation , 2001, Oncogene.

[27]  D. Littman,et al.  Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development , 2002, Cell.

[28]  M. Duvic,et al.  Immunology of AIDS related to psoriasis. , 1990, The Journal of investigative dermatology.